{"id":"W2529971012","doi":"10.1200/jco.2012.30.15_suppl.8517","title":"An open-label, multicenter safety study of vemurafenib (PLX4032, RO5185426) in patients with metastatic melanoma.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Vemurafenib; Medicine; Internal medicine; Clinical endpoint; Rash; Ipilimumab; Adverse effect; Melanoma; Oncology; Metastatic melanoma; Gastroenterology; Dermatology; Surgery; Cancer; Clinical trial; Cancer research; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002079407,0.001027417,0.001602689,0.0003658712,0.0003938561,0.0006578658,0.0005935441,0.000787062,0.003671269],"category_scores_gemma":[0.00177654,0.0004437784,0.001035873,0.0003712957,0.0006035092,0.0007531357,0.0003215515,0.001669992,0.0009645228],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007640499,"about_ca_system_score_gemma":0.0009146472,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004649517,"about_ca_topic_score_gemma":0.0008393724,"domain_scores_codex":[0.9991838,0.0004941309,0.00004276128,0.0001202928,0.00009007515,0.00006886524],"domain_scores_gemma":[0.9984693,0.0002754116,0.0004875959,0.0001086651,0.0001010576,0.0005579103],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7953776,0.04117186,0.03439456,0.000902883,0.002088951,0.0006505564,0.0003652057,0.001374011,0.02971062,0.0001564306,0.004096873,0.08971042],"study_design_scores_gemma":[0.5273824,0.3944243,0.06759571,0.00005158685,0.0008117984,0.001055172,0.00008302507,0.001688002,0.002923532,0.0001572676,0.003792614,0.00003470499],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953406,0.00147579,0.0004367915,0.0001651528,0.00004082193,0.000810679,0.0009544652,0.00005055823,0.0007252296],"genre_scores_gemma":[0.9938261,0.0007500629,0.0008594725,0.0003465149,0.0001894899,0.00104763,0.002015138,0.00001907089,0.0009464884],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003671269,"threshold_uncertainty_score":0.0122816,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09662255233445871,"score_gpt":0.4325496414748005,"score_spread":0.3359270891403418,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}